Lv41
460 积分 2025-07-08 加入
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
29天前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
1个月前
已完结
Mini-PBPK-Based Population Model and Covariate Analysis to Assess the Complex Pharmacokinetics and Pharmacodynamics of RO7449135, an Anti-KLK5/KLK7 Bispecific Antibody in Cynomolgus Monkeys
2个月前
已完结
IgA nephropathy
2个月前
已完结
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
3个月前
已完结
Atrasentan in Patients with IgA Nephropathy
3个月前
已完结
Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
3个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
3个月前
已完结
皖公网安备34019202002308
